168 related articles for article (PubMed ID: 15016741)
21. Clinical outcomes and immune reconstitution in 103 advanced AIDS patients undergoing 12-month highly active antiretroviral therapy.
Dai Y; Qiu ZF; Li TS; Han Y; Zuo LY; Xie J; Ma XJ; Liu ZY; Wang AX
Chin Med J (Engl); 2006 Oct; 119(20):1677-82. PubMed ID: 17097013
[TBL] [Abstract][Full Text] [Related]
22. Intraepithelial gamma/delta T cells in duodenal mucosa are related to the immune state and survival time in AIDS.
Nilssen DE; Müller F; Oktedalen O; Frøland SS; Fausa O; Halstensen TS; Brandtzaeg P
J Virol; 1996 Jun; 70(6):3545-50. PubMed ID: 8648688
[TBL] [Abstract][Full Text] [Related]
23. Association between Highly Active Antiretroviral Therapy and Type of Infectious Respiratory Disease and All-Cause In-Hospital Mortality in Patients with HIV/AIDS: A Case Series.
Báez-Saldaña R; Villafuerte-García A; Cruz-Hervert P; Delgado-Sánchez G; Ferreyra-Reyes L; Ferreira-Guerrero E; Mongua-Rodríguez N; Montero-Campos R; Melchor-Romero A; García-García L
PLoS One; 2015; 10(9):e0138115. PubMed ID: 26379281
[TBL] [Abstract][Full Text] [Related]
24. [Study on the correlation between HIV drug resistance and CD4+ T-lymphocyte of AIDS patients under antiretroviral treatment in Henan province].
Zhu XP; Li H; Liu HW; Yuan Y; Liu CH; Zhu Q; Cui WG; Wang Z
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Dec; 29(12):1181-4. PubMed ID: 19173959
[TBL] [Abstract][Full Text] [Related]
25. [Safety study of 52-week highly active antiretroviral therapy in 198 HIV/AIDS Chinese patients].
Li WJ; Dai Y; Han Y; Qiu ZF; Xie J; Zuo LY; Li YL; Li TS
Zhonghua Yi Xue Za Zhi; 2011 May; 91(19):1318-22. PubMed ID: 21756757
[TBL] [Abstract][Full Text] [Related]
26. Virus-specific antibody production and polyclonal B-cell activation in the intestinal mucosa of HIV-infected individuals.
Eriksson K; Kilander A; Hagberg L; Norkrans G; Holmgren J; Czerkinsky C
AIDS; 1995 Jul; 9(7):695-700. PubMed ID: 7546413
[TBL] [Abstract][Full Text] [Related]
27. The impact of highly active antiretroviral therapy on HIV-specific immune function.
Saag MS
AIDS; 2001 Feb; 15 Suppl 2():S4-10. PubMed ID: 11424976
[TBL] [Abstract][Full Text] [Related]
28. Intestinal mucosal immunoglobulins during human immunodeficiency virus type 1 infection.
Janoff EN; Jackson S; Wahl SM; Thomas K; Peterman JH; Smith PD
J Infect Dis; 1994 Aug; 170(2):299-307. PubMed ID: 8035014
[TBL] [Abstract][Full Text] [Related]
29. [The evaluation of four-year highly active antiretroviral therapy in HIV-1 infected patients].
Deng XJ; He Y; Yang L; Zou SP; Yang H; Zheng YH
Zhonghua Nei Ke Za Zhi; 2011 Mar; 50(3):230-4. PubMed ID: 21600088
[TBL] [Abstract][Full Text] [Related]
30. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
[TBL] [Abstract][Full Text] [Related]
31. Sub-optimal CD4 recovery on long-term suppressive highly active antiretroviral therapy is associated with favourable outcome.
Onen NF; Overton ET; Presti R; Blair C; Powderly WG; Mondy K
HIV Med; 2009 Aug; 10(7):439-46. PubMed ID: 19459993
[TBL] [Abstract][Full Text] [Related]
32. Long-term clinical benefit after highly active antiretroviral therapy in advanced HIV-1 infection, even in patients without immune reconstitution.
Arici C; Ripamonti D; Ravasio V; Maggiolo F; Rizzi M; Finazzi MG; Suter F
Int J STD AIDS; 2001 Sep; 12(9):573-81. PubMed ID: 11516366
[TBL] [Abstract][Full Text] [Related]
33. Inefficacy of intestinal secretory immune response to Cryptosporidium in acquired immunodeficiency syndrome.
Benhamou Y; Kapel N; Hoang C; Matta H; Meillet D; Magne D; Raphael M; Gentilini M; Opolon P; Gobert JG
Gastroenterology; 1995 Mar; 108(3):627-35. PubMed ID: 7875465
[TBL] [Abstract][Full Text] [Related]
34. Declining prevalence of opportunistic gastrointestinal disease in the era of combination antiretroviral therapy.
Mönkemüller KE; Call SA; Lazenby AJ; Wilcox CM
Am J Gastroenterol; 2000 Feb; 95(2):457-62. PubMed ID: 10685750
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of Epstein-Barr Virus Salivary Shedding in HIV/AIDS Patients and HAART Use: A Retrospective Cohort Study.
Yan Y; Ren Y; Chen R; Hu J; Ji Y; Yang J; Shen J; Hu L; Pei H; Wang J; Qiu Y; Lu H; Huang L
Virol Sin; 2018 Jun; 33(3):227-233. PubMed ID: 29654554
[TBL] [Abstract][Full Text] [Related]
36. [Study on the effect of treatment and the status of drug resistance among HIV/AIDS patients treated with highly active antiretroviral therapy in Shandong province].
Zhang J; Lin B; Lin L; Yang PJ; Fu JH; Li HP; Li JY
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Nov; 28(11):1108-11. PubMed ID: 18396667
[TBL] [Abstract][Full Text] [Related]
37. Impact of intensified antiretroviral therapy during early HIV infection on gut immunology and inflammatory blood biomarkers.
Kim CJ; Rousseau R; Huibner S; Kovacs C; Benko E; Shahabi K; Kandel G; Ostrowski M; Kaul R
AIDS; 2017 Jul; 31(11):1529-1534. PubMed ID: 28463882
[TBL] [Abstract][Full Text] [Related]
38. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection.
Bekker V; Scherpbier H; Pajkrt D; Jurriaans S; Zaaijer H; Kuijpers TW
Pediatrics; 2006 Aug; 118(2):e315-22. PubMed ID: 16847077
[TBL] [Abstract][Full Text] [Related]
39. Effect of raltegravir intensification on HIV proviral DNA in the blood and gut mucosa of men on long-term therapy: a randomized controlled trial.
Chege D; Kovacs C; la Porte C; Ostrowski M; Raboud J; Su D; Kandel G; Brunetta J; Kim CJ; Sheth PM; Kaul R; Loutfy MR
AIDS; 2012 Jan; 26(2):167-74. PubMed ID: 22089379
[TBL] [Abstract][Full Text] [Related]
40. HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial.
Ensoli F; Cafaro A; Casabianca A; Tripiciano A; Bellino S; Longo O; Francavilla V; Picconi O; Sgadari C; Moretti S; Cossut MR; Arancio A; Orlandi C; Sernicola L; Maggiorella MT; Paniccia G; Mussini C; Lazzarin A; Sighinolfi L; Palamara G; Gori A; Angarano G; Di Pietro M; Galli M; Mercurio VS; Castelli F; Di Perri G; Monini P; Magnani M; Garaci E; Ensoli B
Retrovirology; 2015 Apr; 12():33. PubMed ID: 25924841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
